

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to pheromone (GO:0019236) | 4.93234412 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 4.74038498 |
| 3 | oxygen transport (GO:0015671) | 4.42129941 |
| 4 | regulation of autophagic vacuole assembly (GO:2000785) | 4.12430747 |
| 5 | regulation of vacuole organization (GO:0044088) | 3.75642156 |
| 6 | sodium ion export (GO:0071436) | 3.72712921 |
| 7 | response to peptidoglycan (GO:0032494) | 3.68554000 |
| 8 | gas transport (GO:0015669) | 3.60435996 |
| 9 | sensory perception of smell (GO:0007608) | 3.59954798 |
| 10 | cellular potassium ion homeostasis (GO:0030007) | 3.56976518 |
| 11 | cellular response to zinc ion (GO:0071294) | 3.51841238 |
| 12 | COPI coating of Golgi vesicle (GO:0048205) | 3.48294257 |
| 13 | Golgi transport vesicle coating (GO:0048200) | 3.48294257 |
| 14 | regulation of mast cell degranulation (GO:0043304) | 3.39436300 |
| 15 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.37547183 |
| 16 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.27886141 |
| 17 | valine metabolic process (GO:0006573) | 3.27051935 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 3.22872107 |
| 19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.21881904 |
| 20 | modulation by symbiont of host immune response (GO:0052553) | 3.21881904 |
| 21 | positive regulation by symbiont of host defense response (GO:0052509) | 3.21881904 |
| 22 | modulation by symbiont of host defense response (GO:0052031) | 3.21881904 |
| 23 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.21881904 |
| 24 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.21881904 |
| 25 | synaptic vesicle maturation (GO:0016188) | 3.21360754 |
| 26 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.19155868 |
| 27 | NADH metabolic process (GO:0006734) | 3.15408312 |
| 28 | tricarboxylic acid metabolic process (GO:0072350) | 3.12055315 |
| 29 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.11595247 |
| 30 | autophagic vacuole fusion (GO:0000046) | 3.07542519 |
| 31 | cellular response to cadmium ion (GO:0071276) | 3.07111194 |
| 32 | activation of protein kinase A activity (GO:0034199) | 3.07012721 |
| 33 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.06008673 |
| 34 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.04344239 |
| 35 | neutrophil activation (GO:0042119) | 3.02343364 |
| 36 | oxaloacetate metabolic process (GO:0006107) | 3.02207553 |
| 37 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.01688997 |
| 38 | cellular response to pH (GO:0071467) | 3.01665885 |
| 39 | lysine metabolic process (GO:0006553) | 3.00167873 |
| 40 | lysine catabolic process (GO:0006554) | 3.00167873 |
| 41 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.97240913 |
| 42 | barbed-end actin filament capping (GO:0051016) | 2.92151611 |
| 43 | positive regulation of B cell differentiation (GO:0045579) | 2.91273257 |
| 44 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.89288876 |
| 45 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.89133778 |
| 46 | respiratory burst (GO:0045730) | 2.87210725 |
| 47 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.85210211 |
| 48 | succinate metabolic process (GO:0006105) | 2.84813795 |
| 49 | mitochondrion degradation (GO:0000422) | 2.84105127 |
| 50 | peroxisome fission (GO:0016559) | 2.83601070 |
| 51 | potassium ion homeostasis (GO:0055075) | 2.80681531 |
| 52 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.80652368 |
| 53 | potassium ion import (GO:0010107) | 2.79348439 |
| 54 | granulocyte activation (GO:0036230) | 2.78492995 |
| 55 | regulation of triglyceride catabolic process (GO:0010896) | 2.76330583 |
| 56 | tricarboxylic acid cycle (GO:0006099) | 2.76105899 |
| 57 | phagosome maturation (GO:0090382) | 2.75718245 |
| 58 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.75107189 |
| 59 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.75107189 |
| 60 | regulation of leukocyte degranulation (GO:0043300) | 2.74227921 |
| 61 | 2-oxoglutarate metabolic process (GO:0006103) | 2.73592068 |
| 62 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.72427910 |
| 63 | cell communication by electrical coupling (GO:0010644) | 2.71694081 |
| 64 | short-chain fatty acid metabolic process (GO:0046459) | 2.70826739 |
| 65 | synaptic vesicle exocytosis (GO:0016079) | 2.69192415 |
| 66 | actin filament polymerization (GO:0030041) | 2.68342073 |
| 67 | male meiosis (GO:0007140) | 2.66889880 |
| 68 | detection of other organism (GO:0098543) | 2.66846022 |
| 69 | synaptonemal complex assembly (GO:0007130) | 2.63208068 |
| 70 | regulation of cilium movement (GO:0003352) | 2.62688441 |
| 71 | thrombin receptor signaling pathway (GO:0070493) | 2.62274129 |
| 72 | sequestering of actin monomers (GO:0042989) | 2.61681386 |
| 73 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.61573691 |
| 74 | detection of bacterium (GO:0016045) | 2.61215853 |
| 75 | cellular sodium ion homeostasis (GO:0006883) | 2.60901018 |
| 76 | neuromuscular process controlling posture (GO:0050884) | 2.58365699 |
| 77 | fatty acid beta-oxidation (GO:0006635) | 2.56710619 |
| 78 | alpha-linolenic acid metabolic process (GO:0036109) | 2.56119511 |
| 79 | regulation of regulated secretory pathway (GO:1903305) | 2.55287683 |
| 80 | regulation of mast cell activation (GO:0033003) | 2.53956419 |
| 81 | response to methylmercury (GO:0051597) | 2.53076086 |
| 82 | relaxation of smooth muscle (GO:0044557) | 2.52892959 |
| 83 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.52737114 |
| 84 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.52564473 |
| 85 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.51040712 |
| 86 | negative regulation of cell killing (GO:0031342) | 2.51040712 |
| 87 | positive regulation of mast cell activation (GO:0033005) | 2.49320973 |
| 88 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.49235305 |
| 89 | protein insertion into membrane (GO:0051205) | 2.48678402 |
| 90 | piRNA metabolic process (GO:0034587) | 2.48528828 |
| 91 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.48517986 |
| 92 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.48166627 |
| 93 | fatty acid catabolic process (GO:0009062) | 2.47939255 |
| 94 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.46037017 |
| 95 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.45191832 |
| 96 | positive regulation of mast cell degranulation (GO:0043306) | 2.45191832 |
| 97 | aspartate family amino acid catabolic process (GO:0009068) | 2.44396882 |
| 98 | UV protection (GO:0009650) | 2.43759742 |
| 99 | detection of calcium ion (GO:0005513) | 2.43298810 |
| 100 | potassium ion export (GO:0071435) | 2.43209566 |
| 101 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.43149449 |
| 102 | neuronal action potential propagation (GO:0019227) | 2.43134015 |
| 103 | amino sugar catabolic process (GO:0046348) | 2.42646398 |
| 104 | positive regulation of catecholamine secretion (GO:0033605) | 2.42460322 |
| 105 | regulation of synaptic vesicle transport (GO:1902803) | 2.42294525 |
| 106 | protein polymerization (GO:0051258) | 2.41683883 |
| 107 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.41545892 |
| 108 | glutamate secretion (GO:0014047) | 2.41026047 |
| 109 | creatine metabolic process (GO:0006600) | 2.40735700 |
| 110 | virion assembly (GO:0019068) | 2.40495376 |
| 111 | protein retention in ER lumen (GO:0006621) | 2.40487080 |
| 112 | response to acidic pH (GO:0010447) | 2.39721574 |
| 113 | regulation of ARF GTPase activity (GO:0032312) | 2.39681580 |
| 114 | fatty acid oxidation (GO:0019395) | 2.37989396 |
| 115 | regulation of synapse structural plasticity (GO:0051823) | 2.36952005 |
| 116 | diacylglycerol metabolic process (GO:0046339) | 2.36896852 |
| 117 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.36779840 |
| 118 | L-phenylalanine metabolic process (GO:0006558) | 2.36779840 |
| 119 | lipid oxidation (GO:0034440) | 2.36714496 |
| 120 | heme biosynthetic process (GO:0006783) | 2.36320320 |
| 121 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.36297286 |
| 122 | xenobiotic catabolic process (GO:0042178) | 2.35711115 |
| 123 | adenosine receptor signaling pathway (GO:0001973) | 2.35488208 |
| 124 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176) | 2.35321637 |
| 125 | transferrin transport (GO:0033572) | 2.35116432 |
| 126 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.34076946 |
| 127 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.34076946 |
| 128 | myeloid cell activation involved in immune response (GO:0002275) | 2.33253961 |
| 129 | leukocyte degranulation (GO:0043299) | 2.33133101 |
| 130 | response to mercury ion (GO:0046689) | 2.32935041 |
| 131 | L-phenylalanine catabolic process (GO:0006559) | 2.32573264 |
| 132 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.32573264 |
| 133 | regulation of cellular extravasation (GO:0002691) | 2.32551461 |
| 134 | lipoxygenase pathway (GO:0019372) | 2.32143384 |
| 135 | sensory perception of chemical stimulus (GO:0007606) | 2.32068349 |
| 136 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.31781659 |
| 137 | regulation of oxidative phosphorylation (GO:0002082) | 2.31145032 |
| 138 | organelle membrane fusion (GO:0090174) | 2.30914060 |
| 139 | macrophage activation involved in immune response (GO:0002281) | 2.30441651 |
| 140 | synaptonemal complex organization (GO:0070193) | 2.30238038 |
| 141 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.29801387 |
| 142 | detection of external biotic stimulus (GO:0098581) | 2.29043163 |
| 143 | receptor recycling (GO:0001881) | 2.28709918 |
| 144 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.28433811 |
| 145 | regulation of beta-amyloid formation (GO:1902003) | 2.27440965 |
| 146 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.27316576 |
| 147 | cofactor catabolic process (GO:0051187) | 2.27269713 |
| 148 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.26577640 |
| 149 | viral protein processing (GO:0019082) | 2.25351875 |
| 150 | amyloid precursor protein catabolic process (GO:0042987) | 2.25326691 |
| 151 | membrane depolarization during action potential (GO:0086010) | 2.25283122 |
| 152 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.24382338 |
| 153 | sialylation (GO:0097503) | 2.23798375 |
| 154 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.23756165 |
| 155 | pentose-phosphate shunt (GO:0006098) | 2.23711015 |
| 156 | fatty acid homeostasis (GO:0055089) | 2.23121795 |
| 157 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.23031220 |
| 158 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.22671560 |
| 159 | regulation of microtubule-based movement (GO:0060632) | 2.22656340 |
| 160 | mannose metabolic process (GO:0006013) | 2.22637719 |
| 161 | regulation of actin nucleation (GO:0051125) | 2.22506351 |
| 162 | ganglioside metabolic process (GO:0001573) | 2.22078699 |
| 163 | regulation of lipoprotein particle clearance (GO:0010984) | 2.22045317 |
| 164 | negative regulation of microtubule polymerization (GO:0031115) | 2.20423609 |
| 165 | regulation of fatty acid oxidation (GO:0046320) | 2.20423068 |
| 166 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.19715947 |
| 167 | cellular response to glucagon stimulus (GO:0071377) | 2.18930033 |
| 168 | thioester biosynthetic process (GO:0035384) | 2.18676800 |
| 169 | acyl-CoA biosynthetic process (GO:0071616) | 2.18676800 |
| 170 | glycogen catabolic process (GO:0005980) | 2.18103234 |
| 171 | membrane repolarization (GO:0086009) | 2.17764900 |
| 172 | cholesterol catabolic process (GO:0006707) | 2.17683961 |
| 173 | sterol catabolic process (GO:0016127) | 2.17683961 |
| 174 | beta-amyloid metabolic process (GO:0050435) | 2.17290702 |
| 175 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.16775206 |
| 176 | cysteine metabolic process (GO:0006534) | 2.16450042 |
| 177 | monocarboxylic acid catabolic process (GO:0072329) | 2.15993093 |
| 178 | regulation of cholesterol metabolic process (GO:0090181) | 2.15437980 |
| 179 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.15222649 |
| 180 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.15222649 |
| 181 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.14989101 |
| 182 | protein import into peroxisome matrix (GO:0016558) | 2.14964689 |
| 183 | mating behavior (GO:0007617) | 2.14742744 |
| 184 | macroautophagy (GO:0016236) | 2.14311342 |
| 185 | ethanol oxidation (GO:0006069) | 2.14072418 |
| 186 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.12370200 |
| 187 | cell communication involved in cardiac conduction (GO:0086065) | 2.10698595 |
| 188 | heme metabolic process (GO:0042168) | 2.09976132 |
| 189 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.09784808 |
| 190 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.09364032 |
| 191 | sulfur amino acid catabolic process (GO:0000098) | 2.09256013 |
| 192 | cAMP biosynthetic process (GO:0006171) | 2.09044638 |
| 193 | neurotransmitter secretion (GO:0007269) | 2.06632674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.52934452 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.72249116 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.23297320 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 3.02285203 |
| 5 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.64385070 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.57809686 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.52592026 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.50220317 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.49749441 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.38343721 |
| 11 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.26182955 |
| 12 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.19965193 |
| 13 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.17646083 |
| 14 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.11138701 |
| 15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.07539049 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.04141188 |
| 17 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.89254101 |
| 18 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.86209159 |
| 19 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.86081220 |
| 20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.84596414 |
| 21 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.81279135 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.74353746 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71424610 |
| 24 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.71095010 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.67949270 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.66495538 |
| 27 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.64545058 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 1.64521662 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60671088 |
| 30 | GATA1_19941826_ChIP-Seq_K562_Human | 1.60424656 |
| 31 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.60198240 |
| 32 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58123038 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.57899865 |
| 34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.56285325 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.56013504 |
| 36 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.54473726 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.51467931 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.50160249 |
| 39 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48490712 |
| 40 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.48333178 |
| 41 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.48110403 |
| 42 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.47297903 |
| 43 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.45096509 |
| 44 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.44426448 |
| 45 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43239459 |
| 46 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.42965050 |
| 47 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.42872107 |
| 48 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42616421 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.42167267 |
| 50 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.40754274 |
| 51 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.40505544 |
| 52 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40268361 |
| 53 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.40223935 |
| 54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38821671 |
| 55 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.37912308 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.37297174 |
| 57 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.36678281 |
| 58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36387737 |
| 59 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.34993626 |
| 60 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33730055 |
| 61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32497405 |
| 62 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.32105093 |
| 63 | MAF_26560356_Chip-Seq_TH2_Human | 1.31408694 |
| 64 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.31271285 |
| 65 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.31114612 |
| 66 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.28690934 |
| 67 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.28643826 |
| 68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27312826 |
| 69 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.27128409 |
| 70 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.26396099 |
| 71 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.26327182 |
| 72 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.26151119 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.25824543 |
| 74 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.25272569 |
| 75 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.25138405 |
| 76 | P68_20966046_ChIP-Seq_HELA_Human | 1.23933372 |
| 77 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.22486709 |
| 78 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.20464273 |
| 79 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.20281838 |
| 80 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20072369 |
| 81 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.19747513 |
| 82 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.19427703 |
| 83 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.19341582 |
| 84 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.19267576 |
| 85 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.19162352 |
| 86 | KDM2B_26808549_Chip-Seq_K562_Human | 1.18351549 |
| 87 | P300_27268052_Chip-Seq_Bcells_Human | 1.17467786 |
| 88 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.17258757 |
| 89 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.17013775 |
| 90 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.15741436 |
| 91 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15721714 |
| 92 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15419561 |
| 93 | MAF_26560356_Chip-Seq_TH1_Human | 1.14853927 |
| 94 | ERA_21632823_ChIP-Seq_H3396_Human | 1.14435278 |
| 95 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.14175280 |
| 96 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13814741 |
| 97 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.13806790 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13345419 |
| 99 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.12694417 |
| 100 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12155727 |
| 101 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11127320 |
| 102 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.10920637 |
| 103 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10838002 |
| 104 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.10119190 |
| 105 | GATA2_19941826_ChIP-Seq_K562_Human | 1.10080350 |
| 106 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10059072 |
| 107 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.09788644 |
| 108 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.09286720 |
| 109 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.09281823 |
| 110 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09115237 |
| 111 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.08698248 |
| 112 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08642069 |
| 113 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08464059 |
| 114 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.07739192 |
| 115 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.07543633 |
| 116 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07084209 |
| 117 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.05723914 |
| 118 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.04984973 |
| 119 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04766248 |
| 120 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.04610275 |
| 121 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.04573408 |
| 122 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.02557684 |
| 123 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.02388482 |
| 124 | SA1_27219007_Chip-Seq_Bcells_Human | 1.01775415 |
| 125 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.00321323 |
| 126 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.99676841 |
| 127 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.99199536 |
| 128 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.98675749 |
| 129 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.98675749 |
| 130 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.97876137 |
| 131 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97406511 |
| 132 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96950616 |
| 133 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.95745163 |
| 134 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.93499694 |
| 135 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.93282004 |
| 136 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.92223898 |
| 137 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92116690 |
| 138 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92050659 |
| 139 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.91756185 |
| 140 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.91251196 |
| 141 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.91242628 |
| 142 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.91200984 |
| 143 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.91200984 |
| 144 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.90164393 |
| 145 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.90076645 |
| 146 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.90016510 |
| 147 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.88398848 |
| 148 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.88299919 |
| 149 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.88151141 |
| 150 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.87068462 |
| 151 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.87040764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008004_abnormal_stomach_pH | 3.95234588 |
| 2 | MP0003724_increased_susceptibility_to | 3.67899513 |
| 3 | MP0001984_abnormal_olfaction | 3.38094518 |
| 4 | MP0005464_abnormal_platelet_physiology | 3.22680492 |
| 5 | MP0003303_peritoneal_inflammation | 2.92153270 |
| 6 | MP0004147_increased_porphyrin_level | 2.81216642 |
| 7 | MP0003436_decreased_susceptibility_to | 2.75778179 |
| 8 | MP0002909_abnormal_adrenal_gland | 2.74582037 |
| 9 | MP0003656_abnormal_erythrocyte_physiolo | 2.70910111 |
| 10 | MP0003329_amyloid_beta_deposits | 2.61933507 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.58199187 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.54858361 |
| 13 | MP0009840_abnormal_foam_cell | 2.47831989 |
| 14 | MP0002132_abnormal_respiratory_system | 2.35320885 |
| 15 | MP0004859_abnormal_synaptic_plasticity | 2.34619056 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 2.32176425 |
| 17 | MP0008260_abnormal_autophagy | 2.30152809 |
| 18 | MP0009278_abnormal_bone_marrow | 2.22762615 |
| 19 | MP0001545_abnormal_hematopoietic_system | 2.20861871 |
| 20 | MP0005397_hematopoietic_system_phenotyp | 2.20861871 |
| 21 | MP0000343_altered_response_to | 2.16805445 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.12115058 |
| 23 | MP0004145_abnormal_muscle_electrophysio | 2.08042477 |
| 24 | MP0000013_abnormal_adipose_tissue | 2.06096896 |
| 25 | MP0004043_abnormal_pH_regulation | 2.00265225 |
| 26 | MP0004130_abnormal_muscle_cell | 1.94962763 |
| 27 | MP0002419_abnormal_innate_immunity | 1.94476001 |
| 28 | MP0000465_gastrointestinal_hemorrhage | 1.93989857 |
| 29 | MP0001835_abnormal_antigen_presentation | 1.91969204 |
| 30 | MP0005025_abnormal_response_to | 1.88423177 |
| 31 | MP0009785_altered_susceptibility_to | 1.84246655 |
| 32 | MP0005360_urolithiasis | 1.83284566 |
| 33 | MP0000604_amyloidosis | 1.80809847 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.70253782 |
| 35 | MP0008875_abnormal_xenobiotic_pharmacok | 1.70226268 |
| 36 | MP0001905_abnormal_dopamine_level | 1.68198439 |
| 37 | MP0000751_myopathy | 1.67473831 |
| 38 | MP0005365_abnormal_bile_salt | 1.67260621 |
| 39 | MP0001529_abnormal_vocalization | 1.65400652 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.65021975 |
| 41 | MP0000569_abnormal_digit_pigmentation | 1.64765185 |
| 42 | MP0003646_muscle_fatigue | 1.62521974 |
| 43 | MP0003635_abnormal_synaptic_transmissio | 1.62376820 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.61920258 |
| 45 | MP0010329_abnormal_lipoprotein_level | 1.60936968 |
| 46 | MP0004215_abnormal_myocardial_fiber | 1.58534063 |
| 47 | MP0005394_taste/olfaction_phenotype | 1.55421581 |
| 48 | MP0005499_abnormal_olfactory_system | 1.55421581 |
| 49 | MP0005000_abnormal_immune_tolerance | 1.54455923 |
| 50 | MP0003806_abnormal_nucleotide_metabolis | 1.53570803 |
| 51 | MP0002822_catalepsy | 1.53308297 |
| 52 | MP0009046_muscle_twitch | 1.52664612 |
| 53 | MP0005670_abnormal_white_adipose | 1.50712773 |
| 54 | MP0005083_abnormal_biliary_tract | 1.48082228 |
| 55 | MP0005451_abnormal_body_composition | 1.45773513 |
| 56 | MP0006082_CNS_inflammation | 1.44906904 |
| 57 | MP0002272_abnormal_nervous_system | 1.44771020 |
| 58 | MP0000749_muscle_degeneration | 1.41900932 |
| 59 | MP0003195_calcinosis | 1.41871175 |
| 60 | MP0004858_abnormal_nervous_system | 1.41834138 |
| 61 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.41168679 |
| 62 | MP0008569_lethality_at_weaning | 1.40214920 |
| 63 | MP0005085_abnormal_gallbladder_physiolo | 1.39317586 |
| 64 | MP0008789_abnormal_olfactory_epithelium | 1.36668900 |
| 65 | MP0005166_decreased_susceptibility_to | 1.36630022 |
| 66 | MP0004036_abnormal_muscle_relaxation | 1.36446152 |
| 67 | MP0001533_abnormal_skeleton_physiology | 1.34715205 |
| 68 | MP0003075_altered_response_to | 1.34449770 |
| 69 | MP0002064_seizures | 1.34231058 |
| 70 | MP0010386_abnormal_urinary_bladder | 1.33001548 |
| 71 | MP0000747_muscle_weakness | 1.31420661 |
| 72 | MP0002723_abnormal_immune_serum | 1.29021678 |
| 73 | MP0003828_pulmonary_edema | 1.28221635 |
| 74 | MP0009643_abnormal_urine_homeostasis | 1.27835968 |
| 75 | MP0005535_abnormal_body_temperature | 1.27475276 |
| 76 | MP0002118_abnormal_lipid_homeostasis | 1.27181205 |
| 77 | MP0003183_abnormal_peptide_metabolism | 1.26976864 |
| 78 | MP0003633_abnormal_nervous_system | 1.26955825 |
| 79 | MP0005636_abnormal_mineral_homeostasis | 1.25960933 |
| 80 | MP0001765_abnormal_ion_homeostasis | 1.24935566 |
| 81 | MP0002420_abnormal_adaptive_immunity | 1.24644339 |
| 82 | MP0002078_abnormal_glucose_homeostasis | 1.24303862 |
| 83 | MP0006054_spinal_hemorrhage | 1.23707106 |
| 84 | MP0001790_abnormal_immune_system | 1.23075145 |
| 85 | MP0005387_immune_system_phenotype | 1.23075145 |
| 86 | MP0004510_myositis | 1.23029315 |
| 87 | MP0001819_abnormal_immune_cell | 1.22578325 |
| 88 | MP0000003_abnormal_adipose_tissue | 1.18961801 |
| 89 | MP0000015_abnormal_ear_pigmentation | 1.18441110 |
| 90 | MP0001968_abnormal_touch/_nociception | 1.18243334 |
| 91 | MP0002452_abnormal_antigen_presenting | 1.16366660 |
| 92 | MP0001502_abnormal_circadian_rhythm | 1.15459092 |
| 93 | MP0008961_abnormal_basal_metabolism | 1.15050307 |
| 94 | MP0002733_abnormal_thermal_nociception | 1.14153636 |
| 95 | MP0001800_abnormal_humoral_immune | 1.13788309 |
| 96 | MP0004270_analgesia | 1.12929414 |
| 97 | MP0005645_abnormal_hypothalamus_physiol | 1.12249130 |
| 98 | MP0002269_muscular_atrophy | 1.11712940 |
| 99 | MP0001501_abnormal_sleep_pattern | 1.11299433 |
| 100 | MP0001845_abnormal_inflammatory_respons | 1.10997879 |
| 101 | MP0003252_abnormal_bile_duct | 1.10346298 |
| 102 | MP0002735_abnormal_chemical_nociception | 1.10077098 |
| 103 | MP0008469_abnormal_protein_level | 1.09926537 |
| 104 | MP0005332_abnormal_amino_acid | 1.09309972 |
| 105 | MP0001986_abnormal_taste_sensitivity | 1.07457016 |
| 106 | MP0002734_abnormal_mechanical_nocicepti | 1.07266852 |
| 107 | MP0009745_abnormal_behavioral_response | 1.07131469 |
| 108 | MP0010155_abnormal_intestine_physiology | 1.05978171 |
| 109 | MP0003879_abnormal_hair_cell | 1.05377036 |
| 110 | MP0001970_abnormal_pain_threshold | 1.04556100 |
| 111 | MP0002736_abnormal_nociception_after | 1.03021941 |
| 112 | MP0005671_abnormal_response_to | 1.02394649 |
| 113 | MP0000230_abnormal_systemic_arterial | 1.02054582 |
| 114 | MP0002067_abnormal_sensory_capabilities | 1.01234650 |
| 115 | MP0002063_abnormal_learning/memory/cond | 1.00271959 |
| 116 | MP0005319_abnormal_enzyme/_coenzyme | 0.99562101 |
| 117 | MP0001666_abnormal_nutrient_absorption | 0.97936952 |
| 118 | MP0005167_abnormal_blood-brain_barrier | 0.97488295 |
| 119 | MP0000372_irregular_coat_pigmentation | 0.96626529 |
| 120 | MP0002090_abnormal_vision | 0.95398790 |
| 121 | MP0000609_abnormal_liver_physiology | 0.94955534 |
| 122 | MP0002653_abnormal_ependyma_morphology | 0.94922862 |
| 123 | MP0009765_abnormal_xenobiotic_induced | 0.94597569 |
| 124 | MP0001944_abnormal_pancreas_morphology | 0.93699639 |
| 125 | MP0002277_abnormal_respiratory_mucosa | 0.90416392 |
| 126 | MP0008995_early_reproductive_senescence | 0.89788807 |
| 127 | MP0005410_abnormal_fertilization | 0.89605856 |
| 128 | MP0001764_abnormal_homeostasis | 0.89061300 |
| 129 | MP0002693_abnormal_pancreas_physiology | 0.87760026 |
| 130 | MP0002971_abnormal_brown_adipose | 0.87682575 |
| 131 | MP0005448_abnormal_energy_balance | 0.84225932 |
| 132 | MP0003880_abnormal_central_pattern | 0.84133538 |
| 133 | MP0005375_adipose_tissue_phenotype | 0.83321722 |
| 134 | MP0008872_abnormal_physiological_respon | 0.83219195 |
| 135 | MP0001756_abnormal_urination | 0.83135516 |
| 136 | MP0003631_nervous_system_phenotype | 0.82966153 |
| 137 | MP0003315_abnormal_perineum_morphology | 0.82775367 |
| 138 | MP0005334_abnormal_fat_pad | 0.82513408 |
| 139 | MP0002229_neurodegeneration | 0.82475954 |
| 140 | MP0009764_decreased_sensitivity_to | 0.81054570 |
| 141 | MP0005330_cardiomyopathy | 0.79993405 |
| 142 | MP0002572_abnormal_emotion/affect_behav | 0.79992589 |
| 143 | MP0003186_abnormal_redox_activity | 0.79378406 |
| 144 | MP0006035_abnormal_mitochondrial_morpho | 0.79016197 |
| 145 | MP0006276_abnormal_autonomic_nervous | 0.78836369 |
| 146 | MP0002184_abnormal_innervation | 0.78691468 |
| 147 | MP0002722_abnormal_immune_system | 0.78225812 |
| 148 | MP0000716_abnormal_immune_system | 0.77936093 |
| 149 | MP0005646_abnormal_pituitary_gland | 0.77813955 |
| 150 | MP0008874_decreased_physiological_sensi | 0.77188708 |
| 151 | MP0003690_abnormal_glial_cell | 0.76908142 |
| 152 | MP0001664_abnormal_digestion | 0.76203827 |
| 153 | MP0004084_abnormal_cardiac_muscle | 0.76194594 |
| 154 | MP0003953_abnormal_hormone_level | 0.75308119 |
| 155 | MP0000685_abnormal_immune_system | 0.74547026 |
| 156 | MP0000689_abnormal_spleen_morphology | 0.73735690 |
| 157 | MP0009763_increased_sensitivity_to | 0.73295908 |
| 158 | MP0002398_abnormal_bone_marrow | 0.72248824 |
| 159 | MP0002405_respiratory_system_inflammati | 0.71481042 |
| 160 | MP0003698_abnormal_male_reproductive | 0.71369027 |
| 161 | MP0003638_abnormal_response/metabolism_ | 0.70858060 |
| 162 | MP0002429_abnormal_blood_cell | 0.69925494 |
| 163 | MP0004883_abnormal_blood_vessel | 0.67443328 |
| 164 | MP0002332_abnormal_exercise_endurance | 0.65175613 |
| 165 | MP0004381_abnormal_hair_follicle | 0.65021415 |
| 166 | MP0002998_abnormal_bone_remodeling | 0.63318499 |
| 167 | MP0001929_abnormal_gametogenesis | 0.62838578 |
| 168 | MP0001849_ear_inflammation | 0.62257742 |
| 169 | MP0005075_abnormal_melanosome_morpholog | 0.60360274 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of macrophages (HP:0004311) | 3.86250167 |
| 2 | Petechiae (HP:0000967) | 3.75956929 |
| 3 | Recurrent abscess formation (HP:0002722) | 3.71054967 |
| 4 | Purpura (HP:0000979) | 3.67876909 |
| 5 | Prolonged bleeding time (HP:0003010) | 3.65305875 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.50322383 |
| 7 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.42077528 |
| 8 | Ketoacidosis (HP:0001993) | 3.34869038 |
| 9 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.23355579 |
| 10 | Dysostosis multiplex (HP:0000943) | 3.20613952 |
| 11 | Eczematoid dermatitis (HP:0000976) | 3.13825020 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 3.05874115 |
| 13 | Ketosis (HP:0001946) | 2.95899228 |
| 14 | Exercise-induced myalgia (HP:0003738) | 2.93786200 |
| 15 | Polyphagia (HP:0002591) | 2.89786675 |
| 16 | Late onset (HP:0003584) | 2.89036159 |
| 17 | Pheochromocytoma (HP:0002666) | 2.85810178 |
| 18 | Cholecystitis (HP:0001082) | 2.85353043 |
| 19 | Abnormal gallbladder physiology (HP:0012438) | 2.85353043 |
| 20 | Epistaxis (HP:0000421) | 2.85263945 |
| 21 | Visual hallucinations (HP:0002367) | 2.84551951 |
| 22 | Retinal dysplasia (HP:0007973) | 2.79148063 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 2.79050438 |
| 24 | Obstructive lung disease (HP:0006536) | 2.79050438 |
| 25 | Myoglobinuria (HP:0002913) | 2.73205263 |
| 26 | Neuroendocrine neoplasm (HP:0100634) | 2.72332891 |
| 27 | Amyloidosis (HP:0011034) | 2.71049832 |
| 28 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.70239799 |
| 29 | Stomatitis (HP:0010280) | 2.67674493 |
| 30 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.64432756 |
| 31 | Abnormality of lateral ventricle (HP:0030047) | 2.58524141 |
| 32 | Absent speech (HP:0001344) | 2.56340390 |
| 33 | Increased cerebral lipofuscin (HP:0011813) | 2.55937004 |
| 34 | Abnormal hemoglobin (HP:0011902) | 2.54941747 |
| 35 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.54348670 |
| 36 | Mucopolysacchariduria (HP:0008155) | 2.54348670 |
| 37 | Colitis (HP:0002583) | 2.54201439 |
| 38 | Supranuclear gaze palsy (HP:0000605) | 2.54164051 |
| 39 | Vacuolated lymphocytes (HP:0001922) | 2.54146340 |
| 40 | Hypoglycemic coma (HP:0001325) | 2.52534278 |
| 41 | Spontaneous hematomas (HP:0007420) | 2.51654804 |
| 42 | Mutism (HP:0002300) | 2.49091393 |
| 43 | Gingival bleeding (HP:0000225) | 2.42362690 |
| 44 | Palpitations (HP:0001962) | 2.42077553 |
| 45 | Gout (HP:0001997) | 2.41178618 |
| 46 | Menorrhagia (HP:0000132) | 2.41122723 |
| 47 | Asymmetric septal hypertrophy (HP:0001670) | 2.40711566 |
| 48 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.40243629 |
| 49 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.40243629 |
| 50 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.40243629 |
| 51 | Myositis (HP:0100614) | 2.39939004 |
| 52 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.39891990 |
| 53 | Oligomenorrhea (HP:0000876) | 2.38386208 |
| 54 | Loss of speech (HP:0002371) | 2.36047868 |
| 55 | Cholelithiasis (HP:0001081) | 2.36016839 |
| 56 | Growth hormone excess (HP:0000845) | 2.35606059 |
| 57 | Myokymia (HP:0002411) | 2.35454308 |
| 58 | Neurofibrillary tangles (HP:0002185) | 2.32838209 |
| 59 | Abnormal gallbladder morphology (HP:0012437) | 2.30431758 |
| 60 | Action tremor (HP:0002345) | 2.30231360 |
| 61 | Depression (HP:0000716) | 2.30003798 |
| 62 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.29986266 |
| 63 | Acute hepatic failure (HP:0006554) | 2.28938067 |
| 64 | Mediastinal lymphadenopathy (HP:0100721) | 2.25794209 |
| 65 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.25729115 |
| 66 | Increased IgM level (HP:0003496) | 2.24613939 |
| 67 | Poikilocytosis (HP:0004447) | 2.22179563 |
| 68 | Polycythemia (HP:0001901) | 2.21786604 |
| 69 | Type II lissencephaly (HP:0007260) | 2.21274576 |
| 70 | Reduced antithrombin III activity (HP:0001976) | 2.20231298 |
| 71 | Hepatocellular necrosis (HP:0001404) | 2.19491934 |
| 72 | Gastrointestinal inflammation (HP:0004386) | 2.19018226 |
| 73 | Microcytic anemia (HP:0001935) | 2.18833388 |
| 74 | Agitation (HP:0000713) | 2.18624609 |
| 75 | Clumsiness (HP:0002312) | 2.18554185 |
| 76 | Increased serum ferritin (HP:0003281) | 2.17684677 |
| 77 | Abnormality of the nasal mucosa (HP:0000433) | 2.17357587 |
| 78 | Hyperbilirubinemia (HP:0002904) | 2.17294573 |
| 79 | Hepatosplenomegaly (HP:0001433) | 2.17162547 |
| 80 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.16643120 |
| 81 | Anxiety (HP:0000739) | 2.15649457 |
| 82 | Reticulocytosis (HP:0001923) | 2.15378807 |
| 83 | Rimmed vacuoles (HP:0003805) | 2.15230916 |
| 84 | Postural instability (HP:0002172) | 2.13846722 |
| 85 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.13708966 |
| 86 | Abnormality of alanine metabolism (HP:0010916) | 2.13708966 |
| 87 | Hyperalaninemia (HP:0003348) | 2.13708966 |
| 88 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.12937886 |
| 89 | Inflammation of the large intestine (HP:0002037) | 2.11989872 |
| 90 | Central scotoma (HP:0000603) | 2.11817927 |
| 91 | Craniofacial dystonia (HP:0012179) | 2.10875107 |
| 92 | Torticollis (HP:0000473) | 2.10688470 |
| 93 | Impaired platelet aggregation (HP:0003540) | 2.09092735 |
| 94 | Abnormal platelet function (HP:0011869) | 2.09092735 |
| 95 | Abnormal platelet volume (HP:0011876) | 2.08456727 |
| 96 | Hypoglycemic seizures (HP:0002173) | 2.07359523 |
| 97 | Granulocytopenia (HP:0001913) | 2.07073541 |
| 98 | Generalized aminoaciduria (HP:0002909) | 2.06710859 |
| 99 | Hypercortisolism (HP:0001578) | 2.06707270 |
| 100 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.05685346 |
| 101 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.05685346 |
| 102 | Xanthomatosis (HP:0000991) | 2.03099781 |
| 103 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.03076022 |
| 104 | Thoracic kyphosis (HP:0002942) | 2.00665709 |
| 105 | Hand muscle atrophy (HP:0009130) | 1.99338528 |
| 106 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99256342 |
| 107 | Neuronal loss in central nervous system (HP:0002529) | 1.99136264 |
| 108 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.98942411 |
| 109 | Brushfield spots (HP:0001088) | 1.98303109 |
| 110 | Ragged-red muscle fibers (HP:0003200) | 1.98207059 |
| 111 | Focal dystonia (HP:0004373) | 1.97446768 |
| 112 | Abnormal pupillary function (HP:0007686) | 1.95695851 |
| 113 | Recurrent skin infections (HP:0001581) | 1.95534584 |
| 114 | Cerebral hemorrhage (HP:0001342) | 1.94031425 |
| 115 | Nasal polyposis (HP:0100582) | 1.93439856 |
| 116 | Encephalitis (HP:0002383) | 1.92768133 |
| 117 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.92167434 |
| 118 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.92167434 |
| 119 | Abnormality of glycolipid metabolism (HP:0010969) | 1.92167434 |
| 120 | Abnormality of purine metabolism (HP:0004352) | 1.92035302 |
| 121 | Abnormality of iron homeostasis (HP:0011031) | 1.91559223 |
| 122 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.89997751 |
| 123 | Myotonia (HP:0002486) | 1.89992420 |
| 124 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.89490260 |
| 125 | Dicarboxylic aciduria (HP:0003215) | 1.89490260 |
| 126 | Amyotrophic lateral sclerosis (HP:0007354) | 1.88997865 |
| 127 | Hyperammonemia (HP:0001987) | 1.88657384 |
| 128 | Urticaria (HP:0001025) | 1.88119052 |
| 129 | Global brain atrophy (HP:0002283) | 1.88028831 |
| 130 | Diminished motivation (HP:0000745) | 1.87721621 |
| 131 | Gonadal dysgenesis (HP:0000133) | 1.87212711 |
| 132 | Abnormality of macular pigmentation (HP:0008002) | 1.87073175 |
| 133 | Retinal atrophy (HP:0001105) | 1.87065412 |
| 134 | Prolonged neonatal jaundice (HP:0006579) | 1.86677303 |
| 135 | Orchitis (HP:0100796) | 1.86035150 |
| 136 | Ankle clonus (HP:0011448) | 1.85456295 |
| 137 | Increased muscle lipid content (HP:0009058) | 1.85144648 |
| 138 | Apathy (HP:0000741) | 1.85135814 |
| 139 | Increased mean platelet volume (HP:0011877) | 1.84596324 |
| 140 | Muscle stiffness (HP:0003552) | 1.84236997 |
| 141 | Cerebral inclusion bodies (HP:0100314) | 1.83802763 |
| 142 | Tinnitus (HP:0000360) | 1.83241880 |
| 143 | Hypertriglyceridemia (HP:0002155) | 1.82256905 |
| 144 | Panhypogammaglobulinemia (HP:0003139) | 1.81958623 |
| 145 | Peripheral hypomyelination (HP:0007182) | 1.81505710 |
| 146 | Cardiomegaly (HP:0001640) | 1.80859735 |
| 147 | Atonic seizures (HP:0010819) | 1.79862984 |
| 148 | Abnormality of the gallbladder (HP:0005264) | 1.76907245 |
| 149 | Disinhibition (HP:0000734) | 1.76805573 |
| 150 | Deep venous thrombosis (HP:0002625) | 1.76696227 |
| 151 | Ventricular fibrillation (HP:0001663) | 1.76659416 |
| 152 | Abnormal eating behavior (HP:0100738) | 1.75507822 |
| 153 | Hepatic necrosis (HP:0002605) | 1.75112853 |
| 154 | Sensorimotor neuropathy (HP:0007141) | 1.75056142 |
| 155 | Hyperlipoproteinemia (HP:0010980) | 1.73500501 |
| 156 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.73303244 |
| 157 | Decreased circulating renin level (HP:0003351) | 1.72397672 |
| 158 | Delusions (HP:0000746) | 1.72385865 |
| 159 | Failure to thrive in infancy (HP:0001531) | 1.72202936 |
| 160 | Large for gestational age (HP:0001520) | 1.72141428 |
| 161 | Hyperactive renin-angiotensin system (HP:0000841) | 1.71565444 |
| 162 | Recurrent fungal infections (HP:0002841) | 1.70639087 |
| 163 | Psychosis (HP:0000709) | 1.70225401 |
| 164 | Intention tremor (HP:0002080) | 1.70173898 |
| 165 | Facial diplegia (HP:0001349) | 1.69934639 |
| 166 | Upper limb amyotrophy (HP:0009129) | 1.69730610 |
| 167 | Distal upper limb amyotrophy (HP:0007149) | 1.69730610 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 3.44970814 |
| 2 | TRIB3 | 3.20414112 |
| 3 | MARK3 | 3.05951838 |
| 4 | CAMKK2 | 3.03873236 |
| 5 | ERN1 | 2.96199003 |
| 6 | BCKDK | 2.86193676 |
| 7 | PHKG1 | 2.36328524 |
| 8 | PHKG2 | 2.36328524 |
| 9 | MAPK15 | 2.33979023 |
| 10 | LMTK2 | 2.32510782 |
| 11 | ARAF | 2.31193655 |
| 12 | KSR2 | 2.19869275 |
| 13 | CSNK1G3 | 1.95346710 |
| 14 | NTRK1 | 1.90518145 |
| 15 | DAPK2 | 1.89050841 |
| 16 | NME2 | 1.86677236 |
| 17 | MAP3K9 | 1.85694310 |
| 18 | TAOK3 | 1.77360298 |
| 19 | CAMKK1 | 1.71666715 |
| 20 | CSNK1G2 | 1.68675662 |
| 21 | PIM2 | 1.65744834 |
| 22 | TESK1 | 1.63469264 |
| 23 | PRKD3 | 1.63251247 |
| 24 | SCYL2 | 1.60266223 |
| 25 | CSNK1A1L | 1.57195559 |
| 26 | KDR | 1.54814235 |
| 27 | GRK6 | 1.52731827 |
| 28 | MAPKAPK5 | 1.50212462 |
| 29 | MAP4K2 | 1.47047027 |
| 30 | SIK1 | 1.44370112 |
| 31 | TNK2 | 1.35150997 |
| 32 | MAP3K13 | 1.34536039 |
| 33 | TYK2 | 1.31218476 |
| 34 | FLT3 | 1.30511613 |
| 35 | MAPKAPK3 | 1.28931352 |
| 36 | CSNK1G1 | 1.26404180 |
| 37 | FGR | 1.25764162 |
| 38 | MAP3K5 | 1.21341339 |
| 39 | PRPF4B | 1.16490574 |
| 40 | ZAP70 | 1.15049559 |
| 41 | MAP3K1 | 1.13910165 |
| 42 | CDK19 | 1.13300725 |
| 43 | INSRR | 1.10336507 |
| 44 | DYRK3 | 1.10190594 |
| 45 | ABL2 | 1.09953671 |
| 46 | SYK | 1.09543246 |
| 47 | TGFBR2 | 1.07948984 |
| 48 | RET | 1.07686047 |
| 49 | PAK6 | 1.07630616 |
| 50 | RIPK1 | 1.06402015 |
| 51 | TBK1 | 1.05463810 |
| 52 | EEF2K | 1.05286057 |
| 53 | PKN2 | 1.01860872 |
| 54 | GRK5 | 1.01717396 |
| 55 | BMX | 1.00855761 |
| 56 | HIPK2 | 1.00577939 |
| 57 | TIE1 | 0.98349440 |
| 58 | HCK | 0.98108428 |
| 59 | JAK1 | 0.96490677 |
| 60 | DYRK2 | 0.96182148 |
| 61 | PDK3 | 0.96155329 |
| 62 | PDK4 | 0.96155329 |
| 63 | RPS6KA5 | 0.95239425 |
| 64 | MAP3K3 | 0.93726247 |
| 65 | NTRK3 | 0.93665436 |
| 66 | MAP4K1 | 0.93222281 |
| 67 | PINK1 | 0.93109632 |
| 68 | PTK2B | 0.92542772 |
| 69 | PDPK1 | 0.90704210 |
| 70 | EPHA3 | 0.90624052 |
| 71 | EPHB1 | 0.88872758 |
| 72 | MINK1 | 0.87883553 |
| 73 | STK38 | 0.87854988 |
| 74 | MOS | 0.87501794 |
| 75 | SIK2 | 0.87057931 |
| 76 | TAOK1 | 0.86302841 |
| 77 | MAP2K4 | 0.86215354 |
| 78 | PRKCH | 0.85784259 |
| 79 | CSK | 0.84722758 |
| 80 | JAK2 | 0.84335178 |
| 81 | ZAK | 0.83850523 |
| 82 | IRAK2 | 0.83570672 |
| 83 | MAP3K2 | 0.83454002 |
| 84 | CCNB1 | 0.82652189 |
| 85 | TAOK2 | 0.82341808 |
| 86 | MAP3K12 | 0.82195808 |
| 87 | GRK7 | 0.81025438 |
| 88 | PTK6 | 0.80952767 |
| 89 | WNK3 | 0.80533307 |
| 90 | MATK | 0.80023633 |
| 91 | CAMK2G | 0.79851219 |
| 92 | PDK1 | 0.79676270 |
| 93 | OBSCN | 0.79241374 |
| 94 | PDK2 | 0.79235358 |
| 95 | MYLK | 0.78482880 |
| 96 | CSF1R | 0.78428370 |
| 97 | LYN | 0.76841999 |
| 98 | MAPK13 | 0.76482743 |
| 99 | DAPK1 | 0.75729505 |
| 100 | WNK4 | 0.75134042 |
| 101 | PIK3CG | 0.74684044 |
| 102 | RAF1 | 0.74647419 |
| 103 | MAPK12 | 0.74337263 |
| 104 | BLK | 0.73239762 |
| 105 | CAMK1 | 0.72323251 |
| 106 | SIK3 | 0.72314586 |
| 107 | PTK2 | 0.71973296 |
| 108 | MAP3K11 | 0.71711341 |
| 109 | CDK8 | 0.71667036 |
| 110 | MAP2K1 | 0.70424736 |
| 111 | PRKCQ | 0.69869195 |
| 112 | CDK5 | 0.68051561 |
| 113 | KIT | 0.68021440 |
| 114 | CAMK2D | 0.67712662 |
| 115 | PKN1 | 0.67596563 |
| 116 | PAK1 | 0.66708933 |
| 117 | PAK3 | 0.65094197 |
| 118 | MAP3K7 | 0.63085370 |
| 119 | MUSK | 0.60479327 |
| 120 | JAK3 | 0.59099157 |
| 121 | CDK14 | 0.58299197 |
| 122 | DYRK1B | 0.58134073 |
| 123 | TTN | 0.57644288 |
| 124 | IRAK4 | 0.57377119 |
| 125 | RPS6KA4 | 0.57370398 |
| 126 | ITK | 0.56509908 |
| 127 | IRAK3 | 0.54902392 |
| 128 | IKBKB | 0.54735132 |
| 129 | MAPK11 | 0.54570600 |
| 130 | IKBKE | 0.53787017 |
| 131 | PRKG2 | 0.53102069 |
| 132 | CAMK1G | 0.52707542 |
| 133 | PRKAA1 | 0.51564725 |
| 134 | MAP2K3 | 0.49212395 |
| 135 | MARK1 | 0.48425364 |
| 136 | BRAF | 0.47688949 |
| 137 | MAP3K4 | 0.45495506 |
| 138 | BTK | 0.45474518 |
| 139 | MAP2K2 | 0.45180588 |
| 140 | TLK1 | 0.45058379 |
| 141 | RIPK4 | 0.44657856 |
| 142 | FGFR4 | 0.44384812 |
| 143 | TEC | 0.44034676 |
| 144 | DAPK3 | 0.43724282 |
| 145 | ADRBK2 | 0.42102170 |
| 146 | NEK9 | 0.42071101 |
| 147 | CAMK2B | 0.41543542 |
| 148 | FES | 0.41095961 |
| 149 | SGK494 | 0.40375517 |
| 150 | SGK223 | 0.40375517 |
| 151 | MARK2 | 0.39209510 |
| 152 | MAP2K7 | 0.38847519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 3.13093220 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.88420693 |
| 3 | Phagosome_Homo sapiens_hsa04145 | 2.68964860 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.56669592 |
| 5 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.51884044 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.39963442 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.39743179 |
| 8 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.16131930 |
| 9 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.03740816 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.90520079 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.83820399 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.83379009 |
| 13 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.75943370 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.75506631 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 1.70367588 |
| 16 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.67487269 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.66988243 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.65743184 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.64599124 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.63642993 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.62313604 |
| 22 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.60366764 |
| 23 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.58525986 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.54495669 |
| 25 | Lysosome_Homo sapiens_hsa04142 | 1.53329428 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.50059253 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.49445317 |
| 28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.43429432 |
| 29 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.42350217 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.41544952 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.40170094 |
| 32 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.39863377 |
| 33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.34930247 |
| 34 | Sulfur relay system_Homo sapiens_hsa04122 | 1.32663474 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.30617101 |
| 36 | Circadian entrainment_Homo sapiens_hsa04713 | 1.27407222 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.26821086 |
| 38 | Pertussis_Homo sapiens_hsa05133 | 1.25092808 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.23360129 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23158548 |
| 41 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.23148715 |
| 42 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.22014693 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21435953 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.21238254 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 1.19908502 |
| 46 | Salivary secretion_Homo sapiens_hsa04970 | 1.19905683 |
| 47 | GABAergic synapse_Homo sapiens_hsa04727 | 1.17025092 |
| 48 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.16689986 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16396456 |
| 50 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.14786726 |
| 51 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.13116099 |
| 52 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.12484697 |
| 53 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.12021801 |
| 54 | Malaria_Homo sapiens_hsa05144 | 1.11292355 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.10706909 |
| 56 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.08489924 |
| 57 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08038882 |
| 58 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.07824512 |
| 59 | Legionellosis_Homo sapiens_hsa05134 | 1.06860736 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.06480522 |
| 61 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.05972931 |
| 62 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.05731306 |
| 63 | Apoptosis_Homo sapiens_hsa04210 | 1.05188605 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.03924074 |
| 65 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.03370238 |
| 66 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.03283808 |
| 67 | Morphine addiction_Homo sapiens_hsa05032 | 1.03266826 |
| 68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.02365236 |
| 69 | Taste transduction_Homo sapiens_hsa04742 | 1.02136563 |
| 70 | Gap junction_Homo sapiens_hsa04540 | 0.99129460 |
| 71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.98885652 |
| 72 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.98548370 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.98546450 |
| 74 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.98425996 |
| 75 | Platelet activation_Homo sapiens_hsa04611 | 0.98272161 |
| 76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.98069495 |
| 77 | Shigellosis_Homo sapiens_hsa05131 | 0.97208674 |
| 78 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.96358941 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.95554956 |
| 80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.94391649 |
| 81 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.93455308 |
| 82 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.92835452 |
| 83 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.92471864 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.91328863 |
| 85 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.90754668 |
| 86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89288126 |
| 87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.88478014 |
| 88 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.86224926 |
| 89 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.86110205 |
| 90 | Salmonella infection_Homo sapiens_hsa05132 | 0.84119072 |
| 91 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.83775785 |
| 92 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.83403077 |
| 93 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.82370628 |
| 94 | Long-term potentiation_Homo sapiens_hsa04720 | 0.81984156 |
| 95 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.81609444 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81235273 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.81067608 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.80570576 |
| 99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79752715 |
| 100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79580533 |
| 101 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79379093 |
| 102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78865178 |
| 103 | Nicotine addiction_Homo sapiens_hsa05033 | 0.78744931 |
| 104 | Renin secretion_Homo sapiens_hsa04924 | 0.78715875 |
| 105 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.78663078 |
| 106 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.78082406 |
| 107 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.77322622 |
| 108 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.77206854 |
| 109 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.76903800 |
| 110 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.76712226 |
| 111 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.76599274 |
| 112 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.74780235 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.74139475 |
| 114 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.73070656 |
| 115 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.72162091 |
| 116 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.72105021 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.71926621 |
| 118 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71833470 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.70997925 |
| 120 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.70108807 |
| 121 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.69244583 |
| 122 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68996242 |
| 123 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.68131083 |
| 124 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67931146 |
| 125 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.67830372 |
| 126 | Viral myocarditis_Homo sapiens_hsa05416 | 0.67556408 |
| 127 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67363479 |
| 128 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.66030593 |
| 129 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.64280412 |
| 130 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.64110214 |
| 131 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.63277446 |
| 132 | Cocaine addiction_Homo sapiens_hsa05030 | 0.62631336 |
| 133 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60978767 |
| 134 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60833789 |
| 135 | Influenza A_Homo sapiens_hsa05164 | 0.60512703 |
| 136 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59692530 |
| 137 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.59467674 |
| 138 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.59278079 |
| 139 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.58470232 |
| 140 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.57788439 |
| 141 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.57720823 |
| 142 | Parkinsons disease_Homo sapiens_hsa05012 | 0.57516612 |
| 143 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.57302692 |
| 144 | Endocytosis_Homo sapiens_hsa04144 | 0.56775706 |
| 145 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55370490 |
| 146 | Alzheimers disease_Homo sapiens_hsa05010 | 0.55369220 |
| 147 | Mineral absorption_Homo sapiens_hsa04978 | 0.55056841 |
| 148 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53492016 |
| 149 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.53400628 |
| 150 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50972797 |
| 151 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50598346 |
| 152 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.48071601 |
| 153 | Alcoholism_Homo sapiens_hsa05034 | 0.47695562 |
| 154 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47195477 |
| 155 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46890286 |
| 156 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46878552 |
| 157 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.46593273 |
| 158 | Huntingtons disease_Homo sapiens_hsa05016 | 0.46476951 |
| 159 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.45884766 |
| 160 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45700448 |
| 161 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45495416 |
| 162 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.44575525 |
| 163 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.43081004 |
| 164 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42140772 |
| 165 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.39420808 |
| 166 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.37855446 |
| 167 | Hepatitis C_Homo sapiens_hsa05160 | 0.36970226 |
| 168 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36627390 |

